ClinicalTrials.Veeva

Menu

Phenylephrine Tumescence for Hemostasis in Surgery for Burn Injury

U

University of Manitoba

Status and phase

Enrolling
Phase 1

Conditions

Blood Loss, Surgical

Treatments

Drug: Phenylephrine

Study type

Interventional

Funder types

Other

Identifiers

NCT01731444
PhenylephrineRCT

Details and patient eligibility

About

The standard of care for treatment of burn injury is to inject a solution of epinephrine under the skin of the injured site in order to reduce blood loss during skin grafting. This solution of epinephrine has been shown to have effects on the body outside the donor site. Some people have increases in heart rate and blood pressure. We will study the effect of a phenylephrine solution in place of an epinephrine solution to control blood loss. We think that phenylephrine will help decrease blood loss and not change blood pressure or heart rate.

The injured area will be injected under the skin and a skin graft will be taken in the same way as we usually do. The only change will be the use of phenylephrine in the solution instead of epinephrine.

Our goal is to find whether or not phenylephrine or epinephrine solution results in a reduction of blood loss without affecting the rest of the body.

Enrollment

24 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

a) Burn injury requiring debridement and grafting between 5-30% TBSA

Exclusion Criteria

  1. Head and neck, hand, foot, or genital burns
  2. On anticoagulants (except NSAIDs)
  3. On monoamine oxidase inhibitor or tricyclic antidepressant
  4. Coronary or peripheral vascular disease
  5. History of arrhythmias
  6. On a Beta-blocker
  7. History of vascular abnormality
  8. Hypertension

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

24 participants in 2 patient groups

Phenylephrine
Experimental group
Description:
20 ug/cc
Treatment:
Drug: Phenylephrine
Epinephrine
Active Comparator group
Description:
1:1000000
Treatment:
Drug: Phenylephrine

Trial contacts and locations

1

Loading...

Central trial contact

Justin Gawaziuk, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems